Singapore, April 9 -- Strategic Move Expands Ascend's Gene Therapy Capabilities and Secures Long-Term Supply Partnership for Beacon Therapeutics' Sight Saving Therapies.

Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics (Beacon). The transaction brings an operational good manufacturing practice (GMP) facility, process and analytical development capabilities, and additional experts to the Ascend team. It also includes a long-term partnership with Beacon to continue manufacturing its products for clinical and commercial use, securing product supply for Beacon and enabling it to focus on clinical development.



"Ascend wa...